InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Rosol Michael Stanley, Directeur Médical. Director active across 1 companies, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 2 reports have been published. The latest transaction was filed on 14 January 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
07,728 shares0
Common Stock
SEC:0001437749-22-001026·
07,728 shares0
Common Stock
SEC:0001437749-22-001026:0·
2 of 2 declarations
About Rosol Michael Stanley
Rosol Michael Stanley is the Chief Medical Officer at NAVIDEA BIOPHARMACEUTICALS, INC. He oversees the company's medical and research initiatives, ensuring that projects meet the highest standards. His expertise is crucial for the development of new therapies.
